Open Access
Volume 20, 2013
Article Number 37
Number of page(s) 6
Published online 21 October 2013

© A. Ogouyèmi-Hounto et al., published by EDP Sciences, 2013

Licence Creative CommonsThis is an Open Access article distributed under the terms of the Creative Commons Attribution License (, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


In Benin, P falciparum infection is among the first diseases and is also responsible for 36% of deaths among children under 5 years (unpublished data from Ministry of Health). Despite the enormous efforts that have been directed toward malaria control and prevention, multiple factors including insecticide resistance in the anopheline vectors, and the emergence and rapid spread of drug-resistant parasite strains are major problems for the control and prevention of malaria. Therefore, the development of an effective malaria vaccine is urgently needed. One of the limitations to the development of this vaccine against P. falciparum is the extensive genetic diversity in parasite populations limiting the efficacy of acquired protective immunity to malaria [6]. Indeed, antigenic diversity is one of the hypotheses advanced to explain the slow acquisition of immunity against malaria in individuals living in malaria-endemic areas [15]. Asexual blood stage antigens, such as merozoite surface protein-1 (msp-1) and merozoite surface protein-2 (msp-2), are considered prime candidates for the development of a malaria vaccine and are also suitable markers for the identification of genetically distinct P. falciparum parasite sub-populations [5]. In Benin a study performed by Issifou et al. [9] noted a high prevalence of multiple infections influenced neither by age nor by season in a group of children and adults with uncomplicated malaria. Since then, no other study has explored the genetic diversity of P. falciparum malaria in Benin. Following scale up of malaria control interventions (massive deployment of insecticide-treated nets and free treatment with ACT) in the country, it is important to reassess genetic diversity of P. falciparum in Benin to better direct control actions. This study aimed to characterize the allelic polymorphism of msp-1 and msp-2 and determined the multiplicity of infection in P. falciparum isolates collected from children with uncomplicated malaria living in the southern Benin.

Patients and methods

Study sites and population

The study was conducted in two highly endemic regions of southern Benin, including the departments of Littoral and Ouémé. Southern Benin is characterized by a sub-equatorial climate and a perennial malaria transmission with two peaks corresponding to the rainy seasons (April–July and mid-September–November) [20]. Children aged 6 months to 15 years who resided in the study sites for more than a period of 6 months were enrolled from May through August 2011. Children visiting the health facilities in the study area and who met the criteria below were enrolled in the study: (i) fever (axillary temperature ≥37.5 °C) or a history of fever within the past 48 h; (ii) P. falciparum mono-infection with parasite density ≥1000 asexual forms per microliter, identified by microscopy on blood smears; (iii) no evidence of a concomitant febrile illness; (iv) no sign/symptoms of severe malaria as defined by WHO [28]; and (v) written informed consent from parents.

Sample collection and laboratory procedures

Venous blood from symptomatic children fulfilling the above criteria was collected systematically on the filter paper. Thick and thin blood smears were prepared and were stained with 10% Giemsa for rapid diagnosis. All thick blood smears were examined against 500 leukocytes. Parasite densities were recorded as the number of parasites/μL of blood, assuming an average leukocyte count of 8000/μL of blood. All slides were read in the health center’s laboratory with external quality control performed on 10% of the negative slides and all positives in the Reference Laboratory of Parasitology of the Centre National Hospitalo Universitaire of Cotonou. Parasite DNA was extracted from filter papers using the Chelex 100 resin methods [19] and stored at −20 °C until use.

Molecular genotyping of the polymorphic genes msp-1 and msp-2

Specific primer pairs were used to amplify block 2 of msp-1 and block 3 of msp-2 [16, 23]. The two genes were amplified by nested PCR, each amplification with conserved or family specific primer pairs, being done separately, as described previously [25]. Analyses of the K1, MAD20, and RO33 allelic families of msp-1 and the 3D7 and FC27 allelic families of msp-2 were performed sequentially in accordance with the genotyping protocol of Snounou et al. [25]. Allele-specific positive controls and DNA free negative controls were included in each set of reactions. Gel photographs were re-scored by visual comparison of DNA fragments and for individual samples, alleles were identified according to band size and the corresponding allele-specific primers used. The size of the PCR products was estimated using a 100 bp DNA ladder marker (Boehringer Mannheim, Marker VI).

Data analysis

The data were entered in the software R version 2.12.0 (R Foundation for Statistical Computing, Vienna, Austria). The distribution of allelic families of msp-1 and msp-2 genes was determined by the number of PCR products corresponding to each family within the total number of samples. The number of patients with more than one amplified PCR fragment within the total population is defined as the frequency of polyclonal infections. The multiplicity of infection (MOI) was calculated as the total number of detected Plasmodium falciparum msp-1, msp-2 genotypes/total number of infected children [12]. Student’s test was used to compare MOI. The chi-square test or Fisher’s exact test was used for proportion comparisons. The p value < 0.05 was chosen as threshold significance for the various statistical tests.

Ethics statement

The Ethical Committee of the School of Medicine and Health Sciences, University of Benin, gave the ethical approval for the study. Written informed consent from head of school and parents was received.


Demographic and parasitological data of the study population

Over a period of 4 months, 93 children meeting the inclusion criteria were recruited to the study. The characteristics of the study population are detailed in Table 1. The children’s ages ranged from 6 months to 15 years (mean age: 7.9 ± 0.4 years). The parasite density ranged from 1,000 to 160,000 parasites/μL with a mean density of 19,093.

Table 1.

Demographic and parasitological data of the study population.

The parasite DNA from the 93 P. falciparum isolates was analyzed for msp-1 and msp-2 genes. The efficiency of msp-1 and msp-2 gene amplification reactions with family-specific primers was 94.6% (88/93) and 99% (92/93), respectively.

Genetic diversity of P. falciparum msp-1 and msp-2 gene

The distribution of the different allelic families of msp-1 and msp-2 genes is shown in Table 2. The K1 family was the predominant allelic type among mixed infections with RO33 (20.5%) and most represented in the overall population (85.2% prevalence) following by the RO33 sequence (83%) without significant difference p > 0.05. For the msp-2 gene, the FC27 family was more represented but the difference was not statistically significant (p = 0.57).

Table 2.

Genetic diversity of P. falciparum.

The number of msp-1 and msp-2 genotypes per isolate ranged from 1 to 9. The MOI was 3.8 ± 0.35 for msp-1 and 3.9 ± 0.30 for msp-2. Multiple infections were found in 87.5% (77/88) of samples for msp-1 and 91.3% (84/93) of samples for msp-2. Overall (msp-1 + msp-2), the multiplicity of infection was 4 PCR fragments per individual infected, with 72 (81.8%) of the samples harboring more than one parasite genotype.

According to age, and parasite density the MOI was similar between individuals of different age and parasite density without significant difference (Table 3).

Table 3.

MOI according age and parasite density.

A total of 53 individual msp alleles were identified (25 for msp-1 and 28 for msp-2).

For the msp-1 gene, 14 K1 type alleles (100–500 bp); 1 RO33-type allele (160 bp) and 10 MAD20 type alleles (100–500 bp) were identified; for the msp-2 gene 16 different FC27 type alleles (250–800 bp) and 12 3D7 type alleles (350–700 bp) were detected. The analysis of K1 alleles revealed three prevalent alleles (200 bp, 250 bp, and 400 bp PCR fragments). The RO33 allele did not show any polymorphism, with only one variant (160 bp). The most prevalent Mad20 type alleles were represented by the Mad20200 and Mad20250 PCR fragments (Figure 1). For the msp-2 gene, the most prevalent alleles were detected by the FC27700, 3D7600, and 3D7700 PCR fragments (Figure 2).

thumbnail Figure 1.

Prevalence of P. falciparum K1, RO33 and MAD20 msp-1 alleles classified by length (in base pairs).

thumbnail Figure 2.

Prevalence of P. falciparum FC27 and 3D7 msp-2 alleles classified by length (in base pairs).


In the Republic of Benin, less attention has been put on the investigation of the genetic diversity of P. falciparum than elsewhere. This study is the second after that conducted by Issifou in 2001 [9]. with intensification of malaria control (scale up of use of insecticide-treated bed nets (ITNs), intermittent preventive treatment to pregnant women, early and obligatory parasitological diagnosis before treatment of clinical cases using artemisinin-based combination therapy (ACT)), it was important to characterize new strains of Plasmodium falciparum found in Benin through the importance of mixed infections and the multiplicity of infections. This study was also important for the country because diversity may influence the degree and the expansion of parasite resistance to antimalarial drugs. A high degree of polymorphism is the basis of a large chromosomal recombination thereby increasing the prevalence of the resistance gene. The purpose of this study was to determine the genetic diversity of P. falciparum using the two most polymorphic regions of msp-1 and msp-2, in malaria symptomatic subjects in southern Benin.

Allele-specific genotyping of msp-1 and msp-2 showed a high genetic diversity in the P. falciparum population studied in southern Benin. The degree of polymorphism found in the present study is also consistent with the high level of malaria transmission in the study area as reported previously [22] with a higher diversity of msp-2 in agreement with other studies [1, 21, 24]. Twenty-five alleles of msp-1 were observed, in which, the K1 allelic family was predominant, consistent with most previous studies [1, 9, 26] but in contrast with one in India [2] showing that the RO33 allele was predominant. The limited polymorphism in the RO33 alleles is similar to the findings of others in African countries [14, 17]. For the msp-2 locus, 28 alleles were found and alleles belonging to FC27 family were most frequently detected. Although this is similar to data reported for a study in Congo [12], it differs from the previous results of Issifou in Benin [9], and Mayengue in Congo Brazzaville [14]. The difference with the results of Issifou may be due to the fact that the study goes far back in the past. Indeed, according to Yuan in Myanmar [29], the majority of alleles showed significant temporal fluctuations through the years. Some genotypes underwent major fluctuations in density, while others were highly stable. It has been shown that parasite polymorphism is poorly evaluated by examination of a single blood sample because genotypes can appear and disappear in a very short time [4, 7]. This occurred faster in the higher transmission areas when compared to lower transmission areas. In the same context, Mayengue et al. [13] had found evidence of intra and inter-individual variation in the number of parasite genotypes present in the different episodes of malaria. These results suggest the need for several studies on several samples in the same region to assess the genetic profile of parasites. In our study, a limited clonal fluctuation to a maximum of three predominant alleles was found, similar to the results observed in Burkina Faso [26] as well as in other countries of low endemicity, and with low polymorphism [3, 8]. The high rate of multiple or mixed P. falciparum infections with msp-1 and msp-2 also found elsewhere [12, 26] would probably be a consequence of high malaria transmission in the study areas where individuals are exposed to frequent mosquito bites and therefore a significant inoculation of parasite populations that are genetically different. Therefore, these results suggest that the degree of transmission affects the occurrence of mixed infections as initially demonstrated in the Snewin study [24]. Actually, the mean MOI of 3.8 (msp-1) and 3.9 (msp-2) was high compared to those reported in Benin and Congo Brazzaville [9, 14] but consistent with those reported from Gabon, Burkina Faso, and Senegal [1, 26, 27]. This high rate of MOI in the present study suggests that despite the intensification of malaria control interventions involving reduction of malaria infection, the parasite population size and transmission intensity has remained high enough to allow effective genetic recombination of the parasites and continued maintenance of genetic diversity. This echoes the Bogreau study which showed that there is no variation of genetic diversity in a population before and after the use of ITNs.

The fact that the MOI was not influenced by age as shown in other countries [11, 18] suggests that the MOI is not directly related to the period of acquisition of immunity in asymptomatic children, but reflects the exposure of subjects to malaria in the endemic area. Thus, a study of the multiplicity of infection and immunity against asexual stages of Plasmodium [12] showed that the samples with the highest multiplicity came from children with significantly lower antibody responses to specific antigens of the asexual parasite. Malaria episodes with many clones would reflect a low level of acquired immunity with consequent limited ability to control the infection. For these authors, the multiplicity of infection with P. falciparum could be a potentially useful parameter in the evaluation of interventions against malaria. Several studies have shown a correlation between the MOI and parasite density, but in our study, the MOI did not increase with higher densities similar to results of other studies conducted elsewhere [10, 18].


These results show a high genetic diversity of populations of P. falciparum isolated in southern Benin. This study has demonstrated once again the link between the high level of transmission, mixed infections and multiplicity of infection already found in other countries in the subregion and elsewhere. The MOI is not influenced either by patient age or by parasite density. However, other longitudinal studies to examine the dynamics of the genetic diversity of P. falciparum, taking into account other factors such as the degree of transmission, the study of the immune response, and studies of genes conferring resistance to antimalarial drugs, are needed to better target malaria control.


We are grateful to the children who participated in the study, as well as to their mothers. We are pleased to thank caregivers from St Luc and Bethesda hospitals, Seme Kpodji health centers, IRD lab workers. The authors declare that they have no competing interests.


  1. Aubouy A, Bakary M, Keundjian A, Mbomat B, Makita JR, Migot-Nabias F, Cot M, Le Bras J, Deloron P. 2003. Combination of drug level measurement and parasite genotyping data for an improved assessment of amodiaquine and sulfadoxine-pyrimethamine efficacy in treating Plasmodium falciparum malaria in Gabonese children. Antimicrobial Agents and Chemotherapy, 47, 231–237. [CrossRef] [PubMed] [Google Scholar]
  2. Bogreau H. 2007. Diversité, multiplicité des infections et résistance aux antipaludiques de Plasmodium falciparum dans un essai contrôlé de moustiquaires imprégnées d’insecticide en zone de forte endémie. [Google Scholar]
  3. Bharti K, Shukla MM, Sharma YD, Singh N. 2012. Genetic diversity in the block 2 region of the merozoite surface protein-1 of Plasmodium falciparum in central India. Malaria Journal, 11, 78. [CrossRef] [PubMed] [Google Scholar]
  4. Druilhe P, Daubersies P, Patarapotikul J, Gentil C, Chene L, Chongsuphajaisiddhi T, Mellouk S, Langsley G. 1998. A primary malarial infection is composed of a very wide range of genetically diverse but elated parasites. Journal of Clinical Investigation, 101, 2008–2016. [CrossRef] [Google Scholar]
  5. Ekala MT, Jouin H, Lekoulou F, Issifou S, Mercereau-Puijalon O, Ntoumi F. 2002. Plasmodium falciparum merozoite surface protein 1 (msp-1): genotyping and humoral responses to allele-specific variants. Acta Tropica, 81, 33–46. [CrossRef] [PubMed] [Google Scholar]
  6. Genton B, Betuela I, Felger I, Al-Yaman F, Anders RF, Saul A, Rare L, Baisor M, Lorry K, Brown GV, Pye D, Irving DO, Smith TA, Beck HP, Alpers MP. 2002. A recombinant blood-stage malaria vaccine reduces Plasmodium falciparum density and exerts selective pressure on parasite populations in a phase 1–2b trial in Papua New Guinea. Journal of Infectious Disease, 185, 820–827. [CrossRef] [Google Scholar]
  7. Guemouri SJ, Boudin C, Fievet N, Ndiaye P, Deloron P. 2006. Plasmodium falciparum genotype population dynamics in asymptomatic children from Senegal. Microbes and Infection, 8, 1663–1670. [CrossRef] [Google Scholar]
  8. Heidari A, Keshavarz H, Rokni MB, Jelinek T. 2007. Genetic diversity in merozoite surface protein msp-1 and msp-2 genes of Plasmodium falciparumin a major endemic region of Iran. Korean Journal of Parasitology, 45, 59–63. [CrossRef] [Google Scholar]
  9. Issifou S, Djikou S, Sanni A, Lekoulou F, Ntoumi F. 2001. Pas d’influence de la saison de transmission ni de l’âge des patients sur la complexité et la diversité génétique des infections dues à Plasmodium falciparum à Cotonou (Bénin). Bulletin de la Société de Pathologie Exotique, 94, 195–198. [Google Scholar]
  10. Khaminsou N, Kritpetcharat O, Daduang J, Charerntanyarak L, Kritpetcharat P. 2011. Genetic analysis of the merozoite surface protein-1 blocks 2 allelic types in Plasmodium falciparum clinical isolates from Lao PDR. Malaria Journal, 10, 371. [CrossRef] [PubMed] [Google Scholar]
  11. Koukouikila-Koussounda F, Malonga V, Mayengue PI, Ndounga M, Vouvoungui CJ, Ntoumi F. 2012. Genetic polymorphism of merozoite surface protein 2 and prevalence of K76T pfcrt mutation in Plasmodium falciparum field isolates from Congolese children with asymptomatic infections. Malaria Journal, 11, 105. [CrossRef] [PubMed] [Google Scholar]
  12. Mayengue PI, Ndounga M, Davy MM, Tandou N, Ntoumi F. 2007. In vivo chloroquine resistance and prevalence of the pfcrt codon 76 mutation in Plasmodium falciparum isolates from the republic of Congo. Acta Tropica, 95, 219–225. [CrossRef] [Google Scholar]
  13. Mayengue PI, Luty AJ, Rogier C, Baragatti M, Kremsner PG, Ntoumi F. 2009. The multiplicity of Plasmodium falciparum infections is associated with acquired immunity to asexual blood stage antigens. Microbes and Infection, 11, 108–111. [CrossRef] [Google Scholar]
  14. Mayengue PI, Ndounga M, Malonga FV, Bitemo M, Ntoumi F. 2011. Genetic polymorphism of merozoite surface protein-1 and merozoite surface protein-2 in Plasmodium falciparum isolates from Brazzaville, Republic of Congo. Malaria Journal, 10, 276. [CrossRef] [PubMed] [Google Scholar]
  15. Mercereau-Puijalon O. 1996. Revisiting host/parasite interactions: molecular analysis of parasites collected during longitudinal and cross-sectional surveys in humans. Parasite Immunology, 18, 173–180. [CrossRef] [PubMed] [Google Scholar]
  16. Miller LH, Roberts T, Shahabuddin M, Mc Cutchan TF. 1993. Analysis of sequence diversity in the Plasmodium falciparum merozoite surface protein-1 (msp-1). Molecular and Biochemical Parasitology, 59, 1–14. [CrossRef] [PubMed] [Google Scholar]
  17. Mwingira F, Nkwengulila G, Schoepflin S, Sumari D, Beck HP, Snounou G, Felger I, Olliaro P, Mugittu K. 2011. Plasmodium falciparum msp-1, msp-2 and glurp allele frequency and diversity in sub-Saharan Africa. Malaria Journal, 10, 79. [CrossRef] [PubMed] [Google Scholar]
  18. Ojurongbe O, Fagbenro-Beyioku AF, Adeyeba OA, Kun JF. 2011. Allelic diversity of merozoite surface protein 2 gene of P. falciparum among children in Osogbo, Nigeria. West Indian Medical journal, 60, 19–23. [Google Scholar]
  19. Plowe CV, Djimde A, Bouare M, Doumbo O, Wellems TE. 1995. Pyrimethamine and proguanil resistance-conferring mutations in Plasmodium falciparum dihydrofolate reductase: polymerase chain reaction methods for surveillance in Africa. American Journal of Tropical Medicine and Hygiene, 52, 565–568. [Google Scholar]
  20. Programme national de lutte contre le paludisme. Plan stratégique de lutte contre le paludisme au Bénin 2006-2010. [Google Scholar]
  21. Schoepflin S, Valsangiacomo F, Lin E, Kiniboro B, Mueller I, Felger I. 2009. Comparison of Plasmodium falciparum allelic frequency distribution in different endemic settings by high-resolution genotyping. Malaria Journal, 8, 250. [CrossRef] [PubMed] [Google Scholar]
  22. Singh N, Shukla MM, Chand G, Bharti PK, Singh MP, Shukla MK, Mehra RK, Sharma RK, Dash AP. 2011. Epidemic of Plasmodium falciparum malaria in Central India, an area where chloroquine has been replaced by artemisinin-based combination therapy. Transactions of the Royal Society of Tropical Medicine and Hygiene, 105, 133–139. [CrossRef] [PubMed] [Google Scholar]
  23. Smythe JA, Peterson MG, Coppel RL, Saul AJ, Kemp DJ, Anders RF. 1990. Structural diversity in the 45-kilodalton merozoite surface antigen of Plasmodium falciparum. Molecular and Biochemical Parasitology, 39, 227–234. [CrossRef] [PubMed] [Google Scholar]
  24. Snewin VA, Herrera M, Sanchez G, Scherf A, Langsley G, Herrera S. 1991. Polymorphism of the alleles of the merozoite surface antigens MSA1 and MSA2 in Plasmodium falciparum wild isolates from Colombia. Molecular and Biochemical Parasitology, 49(2), 265–275. [CrossRef] [PubMed] [Google Scholar]
  25. Snounou G, Zhu X, Siripoon N, Jarra W, Thaithong S, Brown KN, Viriyakosol S. 1999. Biased distribution of msp1 and msp2 allelic variants in Plasmodium falciparum populations in Thailand. Transactions of the Royal Society of Tropical Medicine and Hygiene, 93, 369–377. [CrossRef] [PubMed] [Google Scholar]
  26. Soulama I, Nebie I, Ouedraogo A, Gansane A, Diarra A, Tiono AB, Bougouma EC, Konate AT, Kabre GB, Taylor WRJ, Sirima SB. 2009. Plasmodium falciparum genotypes diversity in symptomatic malaria of children living in an urban and a rural setting in Burkina Faso. Malaria Journal, 8, 135. [CrossRef] [PubMed] [Google Scholar]
  27. Vafa M, Troye-Blomberg M, Anchang J, Garcia A, Migot-Nabias F. 2008. Multiplicity of Plasmodium falciparum infection in asymptomatic children in Senegal: relation to transmission, age and erythrocyte variants. Malaria Journal, 7, 17. [CrossRef] [PubMed] [Google Scholar]
  28. WHO. 2000. Communicable diseases cluster: severe falciparum malaria. Transactions of the Royal Society of Tropical Medicine and Hygiene, 94, 0S1–S9. [Google Scholar]
  29. Yuan L, Zhao H, Wu L, Li X, Parker D, Xu S, Zhao Y, Feng G, Wang Y, Yan G, Fan Q, Yang Z, Cui L. 2013. Plasmodium falciparum populations from northeastern Myanmar display high levels of genetic diversity at multiple antigenic loci. Acta Tropica, 125, 53–59. [CrossRef] [PubMed] [Google Scholar]

Cite this article as: Ogouyèmi-Hounto A, Kinde Gazard D, Ndam N, Topanou E, Garba O, Elegbe P, Hountohotegbe T & Massougbodji A: Genetic polymorphism of merozoite surface protein-1 and merozoite surface protein-2 in Plasmodium falciparum isolates from children in South of Benin. Parasite, 2013, 20, 37.

All Tables

Table 1.

Demographic and parasitological data of the study population.

Table 2.

Genetic diversity of P. falciparum.

Table 3.

MOI according age and parasite density.

All Figures

thumbnail Figure 1.

Prevalence of P. falciparum K1, RO33 and MAD20 msp-1 alleles classified by length (in base pairs).

In the text
thumbnail Figure 2.

Prevalence of P. falciparum FC27 and 3D7 msp-2 alleles classified by length (in base pairs).

In the text

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.